Primary Care Clinics in Scott City, MO Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Saint Francis Clinic Scott City Family Medicine Medicare: Medicare Enrolled Practice Location: 100 E Outer Rd, Scott City, MO 63780 Phone: 573-264-2211 Fax: 573-471-0461 |
Ferguson Medical Group Rural Health Center Inc. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 E Outer Rd, Scott City, MO 63780 Phone: 573-264-2211 Fax: 573-264-2177 |
Saint Francis Clinic Scott City Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 E Outer Rd, Scott City, MO 63780 Phone: 573-264-2211 Fax: 573-471-0461 |
Mcpherson Medical & Diagnostic Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2102 Main St, Scott City, MO 63780 Phone: 573-264-0042 Fax: 573-264-0087 |
Ron Mcculley Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 2520 James St, Scott City, MO 63780 Phone: 573-264-2424 |
Scott City Medical Clinic Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 2102 Main St, Scott City, MO 63780 Phone: 573-264-0042 Fax: 573-264-0087 |
Scott City Medical Center Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 2102 Main St, Scott City, MO 63780 Phone: 573-264-0042 Fax: 573-264-0087 |
News Archive
Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer
Genta Incorporated today announced that the Company has initiated a new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer. Tesetaxel, the leading oral taxane in clinical development, will be evaluated for its use as both first- and second-line chemotherapy.
High costs in McAllen prompt inquiries into physician ownership, self-referral and a major lobbying campaign
Lobbying efforts by Doctors Hospital at Renaissance, in Edinburg, Texas, have steered hundreds of thousands of dollars to key lawmakers in hopes of blocking reforms that would restrict ownership of hospitals by physicians, the Associated Press/Dallas Morning News reports in a follow up to an article in yesterday's New York Times.
Lower dose of clot-busting agent may reduce the need for mechanical clot removal in stroke patients
New research confirms that the lower 0.25 mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.
Researchers develop new assessment to predict risk of falls in long-term care patients
Researchers from Hebrew SeniorLife's Institute for Aging Research have developed and validated a new assessment to predict the risk of falls in long-term care patients. The study on the assessment titled "Fracture Risk Assessment in Long-term Care (FRAiL)" was published today in the Journal of Gerontology Medical Science.
Researchers identify three enterotypes in human intestinal bacteria
It would appear that in terms of composition, the intestinal bacteria of every individual can be divided into three main groups known as enterotypes. The intestinal bacteria in each enterotype organise themselves into distinct, stable clusters displaying common features.
› Verified 5 days ago